Findings
Interoperable medical devices require design considerations for safe information exchange and use, including standards for data format, transmission, and synchronization.
Risk management should address hazards associated with unintended access, corrupted data, and misuse of interfaces.
Verification and validation should include real-world testing to demonstrate safe operation in specified interoperable scenarios and with representative devices or systems.
Clear labeling is critical to minimize risks and guide users in safely connecting and using the device, particularly in systems with multiple components.
Using recognized consensus standards can support device safety and effectiveness but is voluntary; manufacturers can also implement proprietary designs with openly available interface specifications.

Recommendations
Include the purpose of electronic interfaces in device design and premarket submissions, specifying supported device types, data exchange methods, and use cases.
Identify anticipated users (e.g., clinicians, IT professionals, patients) and address their needs in device design, instructions, and labeling.
Conduct a thorough risk analysis to identify hazards related to interoperability, and implement risk controls for safe and effective device use.
Perform verification and validation testing to confirm device performance under normal and abnormal conditions, including interactions with other devices or systems.
Develop labeling that provides detailed instructions, interface specifications, limitations, and warnings for safe device use and integration.

Regulatory Considerations
Premarket submissions for interoperable medical devices must include:
Detailed device descriptions, including the purpose and functionality of electronic interfaces.
Results of risk analyses, verification, and validation testing.
Labeling that supports safe connection and use in interoperable systems.
Devices incorporating standards-based interfaces should include documentation of conformance to those standards.
Manufacturers should specify the intended use and limitations of electronic interfaces to guide users and mitigate risks.
For complex systems involving multiple devices, a systems-based approach should be used to manage shared risks.
Documentation requirements vary based on device risk level and intended use, with detailed test reports required for high-risk systems and summaries acceptable for low-risk cases.